Treat or palliate: Outcomes of hyperelderly myeloma patients.

Limited data are available on outcomes of myeloma in patients over 85 years of age, an age group in which the incidence of myeloma peaks, as these patients are poorly represented in clinical trials. We report a retrospective analysis of treatment patterns and survival outcomes of very old (≥85